| |
| Magyar Radiológusok Társasága |
|
| Nefropatológiai Esetmegbeszélések (2023.11.09.) |
 Rendezvény kezdete: 2023.11.09. | Rendezvény vége: 2023.11.09. |
| Helyszín: Online, |
A Semmelweis Egyetem Nefropatológiai Munkacsoportja és a Belgyógyászati és Onkológiai Klinika nefrológusai örömmel hívják meg a nefrológiával foglalkozó orvosokat/kutatókat a Nefropatológiai Esetmegbeszélések soron következő előadására, melyet online szervezünk. Előadók klinikai részről: dr. Pethő Ákos, dr. Studinger Péter, dr. Ledó Nóra.
Időpont: 2023. november 9. csütörtök, 15:30
Link: https://semmelweis.zoom.us/j/93363012118
Esetek:
64 éves nő. Ismert myeloma multiplex. Lassan romló veseműködés, vizeletében kb. 1 g/die PU. Amyloidosis irányában a biopsziás mintavételek negatív eredményt adtak.
62 éves nő. AML miatt allogén őssejt transzplantáción átesett beteg. IS mellett fokozatosan romló vesefunkció.
44 éves nő. Anamnézisében systema lupus erythematosus, antiphospholipid antitest syndroma. AV-i ganraena miatti b.o. cruralis és j.o. II lábujj amputatiot követően kialakult akut vesekárodás.
Dr. Dobi Deján
egyetemi adjunktus
SE Nefropatológiai munkacsoport
Semmelweis Egyetem
Patológiai, Igazságügyi és Biztosítási Orvostani Intézet |
|
|
 |
| |
| Magyar Immunológiai Társaság |
|
| 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
| Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
| A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
| Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
| A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|
